Document is current
Any future updates will be listed below
-
Authors
Panousis, Nikolaos I.
El Garwany, Omar
Knights, Andrew
Rop, Jesse Cheruiyot https://orcid.org/0000-0003-0054-1782
Kumasaka, Natsuhiko
Imaz, Maria https://orcid.org/0000-0003-1894-8126
Boquete Vilarino, Lorena
Tsingene, Anthi
Tokolyi, Alex
Barnett, Alice https://orcid.org/0009-0001-9544-459X
Gomez, Celine
Anderson, Carl A. https://orcid.org/0000-0003-1719-7009
Gaffney, Daniel J. https://orcid.org/0000-0002-1529-1862
- License Information
-
More Information
Article History
Received: 25 July 2023
Accepted: 23 June 2025
First Online: 27 August 2025
Competing interests
: C.A.A. has received consultancy or lectureship fees from Genomics plc, BridgeBio and GlaxoSmithKline. The rest of the authors declare no competing financial or non-financial interests. D.J.G. was an employee of BioMarin and N.I.P. was an employee of GSK at the time the manuscript was submitted.
